SBRI Healthcare provides funding and support to early-stage projects, enabling testing for business feasibility and technology development, as well as to more mature products by supporting real-world implementation studies. 

The competitions aim to accelerate innovative technologies in the NHS and the wider health and social care system, tackling unmet health and care needs.

Funding is available for phase 1 and 3 of the competition, looking for innovations that can help stroke services, urgent and emergency care, women’s health and Antimicrobial Resistance (AMR).

Competition 25 – AMR and women’s health

Applications close 28 August 2024 1pm. Projects will commence in January 2025. Phase 1 contracts for technical and commercial feasibility testing are valued at up to £100,000 (NET) and will last for six months.

Competition 26 – Urgent & emergency care and stroke 

Applications close 18 September 2024, 1pm. Projects are scheduled to start between January and February 2025. Contracts will last up to 12 months and are valued at up to £500,000 (NET) per project.

Find out more via SBRI’s website. 

Latest Opportunities

UKHAIC opens Flexible Talent Mobility Account (FTMA) funding call

The FTMA is intended to support secondments and other activities that contribute to the mobility…

V Formation is hiring a Digital Marketing Account Manager

V Formation is seeking an experienced digital marketing account manager or senior exec to join our talented, friendly and…

Businesses can apply for the Birmingham City University micro-placement scheme

Micro-placements offer businesses the opportunity to work with a student or graduate free of charge…

Latest News

Common sources of contaminants in cleanrooms and how to prevent them

When a cleanroom is fully operational, all staff are trained and proper protocols are followed,…

Shakespeare Martineau expands employment law team

As part of its strategic growth plans, leading full-service law firm Shakespeare Martineau has expanded…

Upperton continues strategic growth with the appointment of Chief Commercial Officer

Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), continues its growth…